CareTrust CTRE Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by CareTrust in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: CareTrust’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CareTrust's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CareTrust's cash & equivalents?
- CareTrust (CTRE) reported cash & equivalents of $223.21M in Q1 2026.
- How has CareTrust's cash & equivalents changed year-over-year?
- CareTrust's cash & equivalents decreased by 64.7% year-over-year, from $632.51M to $223.21M.
- What is the long-term trend for CareTrust's cash & equivalents?
- Over 5 years (2020 to 2025), CareTrust's cash & equivalents has grown at a 59.9% compound annual growth rate (CAGR), from $18.92M to $198.04M.
- What does cash & equivalents mean?
- The amount of cash and highly liquid investments the company has available immediately.
- How do you interpret cash & equivalents?
- Higher levels provide a buffer for market volatility or acquisition opportunities, while very low levels may indicate liquidity constraints.
- How does cash & equivalents compare across companies?
- Standard across all industries; benchmarked against operational cash burn and debt obligations.